Isaac Odame
#66,632
Most Influential Person Now
Researcher
Isaac Odame's AcademicInfluence.com Rankings
Isaac Odameengineering Degrees
Engineering
#7515
World Rank
#8892
Historical Rank
Biomedical Engineering
#935
World Rank
#952
Historical Rank
Electrical Engineering
#2868
World Rank
#3017
Historical Rank
Applied Physics
#3478
World Rank
#3579
Historical Rank
Download Badge
Engineering
Isaac Odame's Degrees
- Masters Electrical Engineering University of British Columbia
- Bachelors Electrical Engineering University of Ghana
Why Is Isaac Odame Influential?
(Suggest an Edit or Addition)According to Wikipedia, Isaac Odame is a Ghanaian academic and physician who specialises in sickle cell disease. He is a professor of Hematology and Oncology at the Paediatrics department of the University of Toronto. He holds the Alexandra Yeo Chair in Hematology at the University of Toronto. He is the Director of the Hematology Division of the university's Department of Medicine. He is a staff physician of The Hospital for Sick Children, where he serves as the medical director of the Global Sickle Cell Disease Network located at the Centre for Global Child Health. He is a founder of the Global Sickle Cell Disease Network.
Isaac Odame's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial (2016) (344)
- Sickle Cell Disease in Africa (2011) (317)
- Sickle Cell Disease in Africa A Neglected Cause of Early Childhood Mortality (2011) (292)
- Childhood Atypical Teratoid Rhabdoid Tumor of the Central Nervous System: A Meta-Analysis of Observational Studies (2009) (151)
- A global perspective on sickle cell disease (2012) (139)
- Osteopenia, physical activity and health‐related quality of life in survivors of brain tumors treated in childhood (2006) (82)
- Carboplatin hypersensitivity reaction in pediatric patients with low‐grade glioma (2008) (77)
- Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. (2012) (74)
- Pulmonary Langerhans cell histiocytosis: A variable disease in childhood (2006) (72)
- Epidemiological survey of central nervous system germ cell tumors in Canadian children (2007) (69)
- Supratentorial primitive neuroectodermal tumors: a Canadian pediatric brain tumor consortium report (2007) (68)
- Medulloblastoma in the second decade of life: A specific group with respect to toxicity and management (2005) (59)
- The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study (2017) (58)
- Genetic analysis of inherited bone marrow failure syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations (2011) (49)
- Emerging point-of-care technologies for sickle cell disease screening and monitoring (2016) (48)
- Sickle cell disease: Reducing the global disease burden (2019) (47)
- Point‐of‐care screening for sickle cell disease in low‐resource settings: A multi‐center evaluation of HemoTypeSC, a novel rapid test (2018) (45)
- Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline (2018) (43)
- Inadequate dietary intake in patients with thalassemia. (2012) (43)
- Clinical and Genetic Analysis of Unclassifiable Inherited Bone Marrow Failure Syndromes (2008) (42)
- Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin. (2010) (42)
- White Matter Integrity and Core Cognitive Function in Children Diagnosed With Sickle Cell Disease (2009) (41)
- Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. (2006) (41)
- Thermal Pain and Sensory Processing in Children With Sickle Cell Disease (2014) (41)
- TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, randomised controlled trial (2015) (39)
- Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial (2015) (38)
- A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours. (2009) (35)
- Accurate liver T *2 measurement of iron overload: A simulations investigation and in vivo study (2009) (33)
- Outcome of secondary high-grade glioma in children previously treated for a malignant condition: a study of the Canadian Pediatric Brain Tumour Consortium. (2006) (30)
- Transient erythroblastopenia of childhood is an underdiagnosed and self‐limiting disease (2014) (28)
- Higher nocturnal and awake oxygen saturations in children with sickle cell disease receiving hydroxyurea therapy. (2015) (27)
- Impact of a transition program with navigator on loss to follow‐up, medication adherence, and appointment attendance in hemoglobinopathies (2019) (25)
- Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: baseline results from the TWiTCH trial (2015) (23)
- Perspective: We need a global solution (2014) (21)
- Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana. (2011) (20)
- Disease progression in recently diagnosed patients with inherited marrow failure syndromes: A Canadian inherited marrow failure registry (CIMFR) report (2006) (19)
- Liver iron overload assessment by T *2 magnetic resonance imaging in pediatric patients: An accuracy and reproducibility study (2012) (18)
- TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia (2015) (18)
- Effect of Hydroxyurea Therapy on Pulmonary Function in Children with Sickle Cell Anemia. (2017) (17)
- Exploring the Needs of Adolescents With Sickle Cell Disease to Inform a Digital Self-Management and Transitional Care Program: Qualitative Study (2018) (16)
- End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings. (2019) (16)
- Improving Outcomes in Children with Sickle Cell Disease: Treatment Considerations and Strategies (2014) (16)
- Morphine is associated with acute chest syndrome in children hospitalized with sickle cell disease. (2013) (14)
- Introducing the Tran Qol: A New Disease-Specific Quality of Life Measure for Children and Adults with Thalassemia Major (2013) (14)
- Complete response to tacrolimus in a child with severe aplastic anemia resistant to cyclosporin A (2009) (14)
- Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalis. (2016) (13)
- A randomized, placebo-controlled, double-blind trial of canakinumab in children and young adults with sickle cell anemia. (2022) (13)
- Rhesus disease: a global prevention strategy. (2018) (13)
- Predictors of Bacteremia Among Children With Sickle Cell Disease Presenting With Fever (2014) (12)
- Outcomes of haemoglobin Bart’s hydrops fetalis following intrauterine transfusion in Ontario, Canada (2020) (10)
- Hydroxycarbamide treatment in children with Sickle Cell Anaemia is associated with more intact white matter integrity: a quantitative MRI study (2019) (10)
- Assessment of cerebral blood flow with magnetic resonance imaging in children with sickle cell disease: A quantitative comparison with transcranial Doppler ultrasonography (2017) (10)
- The Jamaican historical experience of the impact of educational interventions on sickle cell disease child mortality. (2012) (9)
- Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort. (2009) (6)
- Impact and sustainability of an accredited paediatric nursing training programme in Ghana (2014) (6)
- Immediate Versus Delayed Access of Implantable Venous Access Devices: Does the Timing of Access Make a Difference to the Frequency of Complications? (2003) (6)
- Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned (2021) (6)
- The Impact of the Child with Thalassemia On the Family: Parental Assessment by Child Health Questionnaire. (2009) (5)
- Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell Anemia (2019) (5)
- Agreement Between R2 and R2* Liver Iron Estimates Is Independent of the Type of Iron Removal Therapy: Results from the Twitch Trial (2016) (5)
- Iron overload in transfusion-dependent survivors of hemoglobin Bart’s hydrops fetalis (2018) (5)
- Sickle cell disease: Progress made & challenges ahead (2020) (5)
- Hb S/β+-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the β locus control region (2015) (5)
- Managing sickle cell carrier results generated through newborn screening in Ontario: a precedent-setting policy story (2016) (4)
- Comparing Patterns for Transitioning the Care of Young Adults with Sickle Cell Disease Versus Hemophilia: The Toronto Experience (2011) (4)
- Effectiveness of preoperative screening for sickle cell disease in a population with a newborn screening program: a cohort study (2012) (4)
- Access to hematopoietic stem cell transplant for patients with sickle cell anemia (2018) (4)
- Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young Adults (2016) (3)
- Newborn Screening With Sickle Cell Point of Care: A Valuable Resource in Low-Income Settings (2019) (3)
- SickKids-Caribbean Initiative: collaborating to improve the diagnosis and care of children with cancer and serious blood disorders in the Caribbean (2017) (3)
- Comprehensive Structured Transition Program With Dedicated Transition Navigator Reduced Lost to Follow-Up and Improved Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease and Thalassemia (2017) (3)
- Hydroxyurea Therapy for Sickle Cell Disease in Low-Income Countries (2015) (2)
- An Analysis Of The Pediatric Sub-Group From The Phase 2 Study Of GMI 1070 – A Novel Agent For The Vaso-Occlusive Crisis Of Sickle Cell Anemia (2013) (2)
- Blood diseases in Africa: Redressing unjust disparities is an urgent unmet need (2022) (2)
- Sickle cell disease in Germany: Early insights from a national registry (2020) (1)
- Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin‐H fraction and “functional” haemoglobin level (2022) (1)
- Association of wheeze with lung function decline in children with sickle cell disease (2017) (1)
- The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology (2022) (1)
- Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013 (2018) (1)
- S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL (2022) (1)
- Study Design and Initial Baseline Characteristics in Solace-Kids: Crizanlizumab in Pediatric Patients with Sickle Cell Disease (2020) (1)
- Multispectral imaging for MicroChip electrophoresis enables point-of-care newborn hemoglobin variant screening (2021) (1)
- P1487: SICKLE CELL HEALTH AWARENESS, PERSPECTIVES AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE ON PATIENTS AND THEIR UNMET NEEDS AS REPORTED BY HEALTHCARE PROFESSIONALS (2022) (0)
- Liver Iron Concentration By MRI In Chronically Transfused Children With Sickle Cell Anemia In The Twitch Trial (2013) (0)
- In Remembrance: Dr. Kwaku Ohene-Frempong (2022) (0)
- Risk Factors Predisposing to Thromboembolism in Children with Cancer. (2007) (0)
- 5612992 SICKLE CELL HEALTH AWARENESS, PERSPECTIVES, AND EXPERIENCES (SHAPE) SURVEY: FINDINGS ON THE BURDEN OF SICKLE CELL DISEASE AND IMPACT ON THE QUALITY OF LIFE OF PATIENTS AND CAREGIVERS IN THE UK (2023) (0)
- Carboplatin hypersensitivity reaction in pediatric low grade glioma (LGG) patients: A national experience. On behalf of the Canadian Pediatric Brain Tumor Consortium. (2006) (0)
- Alvin Zipursky (1930–2021): an unsurpassable mentor, counselor, and child health advocate (2021) (0)
- POST Marketing Observational Study of Children (6 years or older) Treated with Deferasirox (Exjade ICL 670)-One Year analysis (2011) (0)
- S129: IMPLEMENTATION OF HYDROXYUREA THERAPY FOR SICKLE CELL DISEASE ON A LARGE SCALE IN GHANA (2022) (0)
- Hydroxyurea for SCA in Africa: no malaria harm. (2017) (0)
- PB2304 CRIZANLIZUMAB DOSE CONFIRMATION IN PEDIATRIC PATIENTS WITH SICKLE CELL DISEASE: SOLACE-KIDS TRIAL DESIGN (2019) (0)
- A Comparison Study of Liver R 2 * Measurement in Pediatric Patients with Iron Overload (2008) (0)
- Sickle Cell Disease (2013) (0)
- HU for SCA in Africa: associated malaria benefit. (2023) (0)
- Changes In Health Status and Quality of Life In Parental Reports of Children with Thalassemia: Year 1 Report of the Thalassemia Longitudinal Cohort Study (2010) (0)
- Initial Safety and Efficacy Results from the Phase II, Multicenter, Open-Label Solace-Kids Trial of Crizanlizumab in Adolescents with Sickle Cell Disease (SCD) (2021) (0)
- Academic Community Standards for Chronic Transfusion Therapy In Children with Sickle Cell Anemia and Abnormal Transcranial Doppler Velocities (2010) (0)
- Barriers and Facilitators to Community Acceptability of Integrating Point-of-Care Testing to Screen for Sickle Cell Disease in Children in Primary Healthcare Settings in Rural Northern Ghana (2022) (0)
- In memoriam: Kwaku Ohene-Frempong (1946 - 2022). (2022) (0)
- Outcome and Clinical Characteristics of Clonal and Malignant Myeloid Transformation in Inherited Bone Marrow Failure Syndromes (2012) (0)
- Sickle cell disease in children: an update of the evidence in low- and middle-income settings (2022) (0)
- Risk Factors for Hyponatremia in Children With Sickle Cell Disease Hospitalized With Vaso-Occlusive Episodes (2011) (0)
This paper list is powered by the following services:
Other Resources About Isaac Odame
What Schools Are Affiliated With Isaac Odame?
Isaac Odame is affiliated with the following schools:
